-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Oncternal Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
- Oncternal Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.85M, a 7.98% increase year-over-year.
- Oncternal Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $6.81M, a 3.81% decline year-over-year.
- Oncternal Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.5M, a 0.93% increase from 2022.
- Oncternal Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.43M, a 26.5% increase from 2021.
- Oncternal Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.88M, a 278% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)